VERNALIS (R&D) LTD has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are BEIJING SCITECH MQ PHARMACEUTICALS LTD, RUGEN HOLDINGS (CAYMAN) LTD and KARUS THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 2 | |
#3 | China | 1 | |
#4 | EAPO (Eurasian Patent Organization) | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hungary | 1 | |
#7 | Republic of Korea | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Electrotherapy | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Stokes Stephen | 6 |
#2 | Ray Stuart Christopher | 4 |
#3 | Stefaniak Emma Jayne | 4 |
#4 | Bedford Simon | 3 |
#5 | Gillespie Roger John | 3 |
#6 | Webb Paul | 3 |
#7 | Brough Paul | 3 |
#8 | Bamford Samantha Jane | 3 |
#9 | Todd Richard Simon | 3 |
#10 | Graham Christopher | 2 |